管理家族性高胆固醇血症的挑战:一个病例报告
Joanna Rogozik1, Marcin Grabowski1, Renata Główczyńska1
1First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Frontiers in cardiovascular medicine
|October 3, 2024
概括
在患有家族性高胆固醇血症 (FH) 的患者中,英克利西兰治疗有效降低了LDL胆固醇,该患者对他类药物不耐受. 这种基于siRNA的治疗方法在其他疗法失败时为FH管理提供了一个有希望的替代方案.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 家族性高胆固醇血症 (FH) 是一种遗传性疾病,导致高的LDL胆固醇和早期心血管疾病风险.
- 异性FH (HeFH) 影响全球大约每500个人中就有1人.
- 达他林不耐受性和其他降脂疗法的有效性有限,在FH管理中构成挑战.
研究的目的:
- 报告一个用inclisiran治疗治理的HeFH病例.
- 为了评估inclisiran在患有他类药物不耐受和特定的LDLR基因突变的患者中的疗效.
- 评估inclisiran作为耐火性FH的治疗选择.
主要方法:
- 一名患有HeFH,确诊的基因突变 (前体7-14的LDLR基因缺失) 和他类药物不耐受症的患者接受了治疗.
- 起初使用阿利罗库马布治疗并没有达到预期的LDL-C降低.
- 进行了因克利西兰治疗 (284毫克),随后对LDL胆固醇水平进行监测.
主要成果:
- 患者表现出对他类药物治疗的不耐受性和对ezetimibe的不充分反应.
- 阿利罗库马布治疗没有产生足够的LDL-C降低.
- 英克利西兰治疗导致3个月后显著的LDL胆固醇降低,并在1年的随访中持续.
结论:
- 英克利西兰疗法是对患有HEFH且患有他类药物不耐受症的患者的有前途的治疗方法.
- 这种基于siRNA的方法针对PCSK9mRNA,在标准疗法不足时为管理高胆固醇血症提供了替代方案.
- 因基因因素和不耐受性而导致治疗选择有限的FH患者,Inclisiran代表了一个有价值的治疗选择.
相关概念视频
01:26Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
01:26Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
01:23Atherosclerosis IV: Nursing Management
2
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
2
01:29Cholesterol: Significance and Regulation
519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
519
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
581
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
581
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70